Market 0Why India's US-Listed ADRs Are Bleeding While Their Home-Market Shares Hold Firmer15 hours ago0000
Business 1Indian Drugmakers Get Tentative US Nod To Sell Cheaper Version Of AstraZeneca's Blockbuster Cancer Drug2 days ago0000
Bihar 5India's Pharma Supply Chain 65% Dependent on China for Raw Materials, NITI Aayog Raises Alarm28 days ago0000